Stocktoria
ENvue Medical, Inc. FEED
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2015-04-24
ENvue Medical, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6M | $2.6M | $2.3M | $752,000 | $1.7M | $623,000 | $530,000 | $318,000 | $239,000 | $229,000 |
| Gross profit | $153,000 | $1.5M | $1.5M | $167,000 | $770,000 | $214,000 | $281,000 | $160,000 | $151,000 | $141,000 |
| R&D expense | $1.8M | $909,000 | $185,000 | $283,000 | $293,000 | $171,000 | $514,000 | $614,000 | $693,000 | $584,000 |
| Operating income | -$22.9M | -$3.6M | -$3.4M | -$5.0M | -$5.7M | -$4.7M | -$5.2M | -$4.3M | -$3.1M | -$2.3M |
| Interest expense | — | $135,000 | $135,000 | $347,000 | — | $147,000 | $15,000 | — | — | — |
| Income tax | -$307,000 | $19,000 | $29,000 | $35,000 | $32,000 | $15,000 | -$17,000 | -$127,000 | $38,000 | $117,000 |
| Net income | -$18.2M | -$3.7M | -$3.7M | -$5.4M | -$14.3M | -$4.3M | -$5.8M | -$4.2M | -$5.0M | -$2.8M |
| EPS (diluted) | $-26.69 | $-137.30 | $-23.32 | $-3.84 | — | — | — | — | — | — |
| Operating cash flow | -$9.4M | -$2.5M | -$3.6M | -$7.0M | -$4.4M | -$3.4M | -$3.9M | -$3.5M | -$2.2M | -$1.5M |
| Free cash flow | -$9.4M | -$2.5M | -$3.6M | -$7.0M | -$4.4M | -$3.4M | — | -$3.6M | — | -$1.5M |
| Cash & equivalents | $4.2M | $752,000 | — | — | $7.7M | $7.1M | $1.3M | $896,000 | $4.4M | $106,000 |
| Inventory | $2.3M | $2.2M | $2.7M | $2.2M | $175,000 | $145,000 | $121,000 | $144,000 | $76,000 | $67,000 |
| Total assets | $41.1M | $3.6M | $6.7M | $5.9M | $8.6M | $8.2M | $2.0M | $1.6M | $4.9M | $494,000 |
| Total liabilities | $7.6M | $3.0M | $2.7M | $2.6M | $2.3M | $5.8M | $688,000 | $1.1M | — | — |
| Shareholders' equity | $33.5M | $627,000 | $4.0M | $3.2M | $6.3M | $2.4M | $1.3M | $463,000 | $3.6M | -$2.5M |
Growth · year-over-year · Revenue CAGR 30.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -0.2% | +12.0% | +203.6% | -55.6% | +172.1% | +17.5% | +66.7% | +33.1% | +4.4% | +55.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.